Pfizer Offered $99 Billion In AstraZeneca Bid - Presented by: The Aol. On Network

Pfizer confirmed today that it had asked AstraZeneca to consider a merger, and been rebuffed. Under U.K. law, it had to disclose the offer and went public with a $98.7 billion offer to buy the London-based drug maker. The deal will be 70% cash and 30% stock, and will provide Pfizer with a way to use funds it has kept out of the U.S. without paying U.S. taxes. The deal would also allow Pfizer to lower its tax rate by creating a holding company in the U.K.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.11 0.18 ▲ 1.13%
AAPL $ 128.95 3.80 ▲ 3.04%
AA $ 14.15 0.73 ▲ 5.44%
CHK $ 16.54 0.77 ▲ 4.88%
TWTR $ 37.84 1.12 ▼ 2.87%
MSFT $ 48.655 0.02 ▲ 0.03%
NOK $ 6.50 0.08 ▼ 1.22%
VALE $ 8.07 0.39 ▲ 5.08%

As of 5/1/2015, 04:15 PM